High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant “high-risk clones” of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals

The type III secretion system of Pseudomonas aeruginosa is an important virulence factor contributing to the cytotoxicity and the invasion process of this microorganism. The current study aimed to determine the presence of the exoU +/ exoS + genotype in P . aeruginosa clinical isolates. The presence...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Scientific reports 2019-07, Vol.9 (1), p.10874-13, Article 10874
Hauptverfasser: Horna, Gertrudis, Amaro, Catherine, Palacios, Aida, Guerra, Humberto, Ruiz, Joaquim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The type III secretion system of Pseudomonas aeruginosa is an important virulence factor contributing to the cytotoxicity and the invasion process of this microorganism. The current study aimed to determine the presence of the exoU +/ exoS + genotype in P . aeruginosa clinical isolates. The presence of exoS , exoT , exoU and exoY was determined in 189 P . aeruginosa by PCR, and the presence/absence of exoU was analysed according to source infection, clonal relationships, biofilm formation, motility and antimicrobial susceptibility. The gyrA , parC , oprD , efflux pump regulators and β-lactamases genes were also analysed by PCR/sequencing. The exoS , exoT and exoY genes were found in 100% of the isolates. Meanwhile, exoU was present in 43/189 (22.8%) of the isolates, being significantly associated with multidrug resistance, extensively drug resistance as well as with higher level quinolone resistance. However, the presence of β-lactamases, mutations in gyrA and parC , and relevant modifications in efflux pumps and OprD were not significantly associated with exoU + isolates. MLST analysis of a subset of 25 isolates showed 8 different STs displaying the exoU +/ exoS + genotype. The MDR basis of the exoU + isolates remain to be elucidated. Furthermore, the clinical implications and spread of exoU +/ exoS +  P . aeruginosa isolates need to be established.
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-019-47303-4